US Stock MarketDetailed Quotes

UroGen Pharma Ltd (URGN)

Watchlist
  • 29.580
  • +0.080+0.27%
Trading Jun 12 09:42 ET
1.44BMarket Cap-10.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

UroGen Pharma Ltd (URGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
151.60%50.96M
21.45%109.79M
54.03%37.84M
9.04%27.48M
10.83%24.22M
7.84%20.25M
9.29%90.4M
4.40%24.57M
20.87%25.2M
3.35%21.85M
Operating revenue
151.60%50.96M
21.45%109.79M
54.03%37.84M
9.04%27.48M
10.83%24.22M
7.84%20.25M
9.29%90.4M
4.40%24.57M
20.87%25.2M
3.35%21.85M
Cost of revenue
77.64%4.14M
40.15%12.45M
33.10%3.29M
33.63%3.28M
59.26%3.55M
34.84%2.33M
-5.13%8.88M
8.09%2.47M
3.63%2.45M
-8.76%2.23M
Gross profit
161.21%46.82M
19.41%97.34M
56.37%34.55M
6.39%24.2M
5.33%20.67M
5.11%17.92M
11.13%81.52M
4.00%22.09M
23.08%22.75M
4.94%19.62M
Operating expense
22.33%67.08M
24.62%222.2M
7.86%53.66M
28.03%51.59M
36.64%62.11M
28.15%54.84M
28.38%178.3M
38.77%49.75M
25.98%40.3M
33.39%45.46M
Selling and administrative expenses
47.24%51.49M
28.02%155.1M
12.88%39.35M
29.86%37.58M
43.73%43.2M
28.09%34.97M
29.89%121.15M
41.98%34.86M
33.03%28.94M
33.62%30.06M
Research and development costs
-21.51%15.6M
17.43%67.11M
-3.89%14.31M
23.36%14.01M
22.80%18.91M
28.25%19.87M
25.28%57.15M
31.78%14.89M
11.00%11.36M
32.96%15.4M
Operating profit
45.11%-20.26M
-29.01%-124.86M
30.89%-19.12M
-56.09%-27.39M
-60.41%-41.45M
-43.41%-36.91M
-47.68%-96.78M
-89.32%-27.66M
-29.96%-17.55M
-67.98%-25.84M
Net non-operating interest income expense
-20.37%-7.76M
-3.15%-27.88M
-5.26%-7.52M
-15.97%-6.82M
7.81%-7.1M
-2.19%-6.45M
19.61%-27.03M
14.61%-7.14M
30.50%-5.88M
11.19%-7.7M
Non-operating interest income
-57.76%931K
-32.99%5.97M
-67.71%908K
-57.34%1.18M
9.32%1.68M
22.58%2.2M
237.03%8.9M
287.33%2.81M
230.18%2.76M
252.64%1.53M
Non-operating interest expense
2.88%4.19M
22.55%15.35M
-3.08%3.77M
23.96%3.37M
19.39%4.13M
66.24%4.07M
-14.91%12.52M
8.53%3.89M
-28.68%2.72M
-7.98%3.46M
Total other finance cost
-1.68%4.51M
-20.96%18.5M
-23.22%4.66M
-21.88%4.62M
-19.56%4.64M
-19.03%4.58M
8.63%23.41M
10.14%6.06M
7.96%5.92M
8.03%5.77M
Other net income (expense)
-258.89%-323K
-192.58%-670K
91.94%-5K
-24.68%-197K
-317.24%-378K
50.82%-90K
-127.33%-229K
-107.64%-62K
-322.54%-158K
680.00%174K
Gain on sale of security
----
----
----
21.88%-4.62M
19.56%-4.64M
19.03%-4.58M
-8.63%-23.41M
-10.14%-6.06M
-7.96%-5.92M
-8.03%-5.77M
Other non- operating income (expenses)
-258.89%-323K
-192.58%-670K
91.94%-5K
-24.68%-197K
-317.24%-378K
50.82%-90K
-127.33%-229K
-107.64%-62K
-322.54%-158K
680.00%174K
Income before tax
34.76%-28.35M
-23.68%-153.42M
23.59%-26.64M
-45.88%-34.4M
-46.64%-48.93M
-34.81%-43.45M
-26.16%-124.04M
-57.31%-34.86M
-7.74%-23.58M
-38.55%-33.37M
Income tax
-1,317.35%-4.77M
-97.25%78K
-110.38%-275K
-1,258.24%-1.05M
2,571.05%1.02M
625.93%392K
-27.76%2.83M
-31.27%2.65M
1,111.11%91K
-29.63%38K
Net income
46.23%-23.57M
-20.98%-153.49M
29.72%-26.36M
-40.87%-33.35M
-49.51%-49.94M
-35.80%-43.84M
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
Net income continuous Operations
46.23%-23.57M
-20.98%-153.49M
29.72%-26.36M
-40.87%-33.35M
-49.51%-49.94M
-35.80%-43.84M
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
Minority interest income
Net income attributable to the parent company
46.23%-23.57M
-20.98%-153.49M
29.72%-26.36M
-40.87%-33.35M
-49.51%-49.94M
-35.80%-43.84M
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
46.23%-23.57M
-20.98%-153.49M
29.72%-26.36M
-40.87%-33.35M
-49.51%-49.94M
-35.80%-43.84M
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
Basic earnings per share
48.91%-0.47
-7.77%-3.19
32.50%-0.54
-35.29%-0.69
-28.05%-1.05
-5.75%-0.92
16.62%-2.96
-21.21%-0.8
25.00%-0.51
20.39%-0.82
Diluted earnings per share
48.91%-0.47
-7.77%-3.19
32.50%-0.54
-35.29%-0.69
-28.05%-1.05
-5.75%-0.92
16.62%-2.96
-21.21%-0.8
25.00%-0.51
20.39%-0.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 151.60%50.96M21.45%109.79M54.03%37.84M9.04%27.48M10.83%24.22M7.84%20.25M9.29%90.4M4.40%24.57M20.87%25.2M3.35%21.85M
Operating revenue 151.60%50.96M21.45%109.79M54.03%37.84M9.04%27.48M10.83%24.22M7.84%20.25M9.29%90.4M4.40%24.57M20.87%25.2M3.35%21.85M
Cost of revenue 77.64%4.14M40.15%12.45M33.10%3.29M33.63%3.28M59.26%3.55M34.84%2.33M-5.13%8.88M8.09%2.47M3.63%2.45M-8.76%2.23M
Gross profit 161.21%46.82M19.41%97.34M56.37%34.55M6.39%24.2M5.33%20.67M5.11%17.92M11.13%81.52M4.00%22.09M23.08%22.75M4.94%19.62M
Operating expense 22.33%67.08M24.62%222.2M7.86%53.66M28.03%51.59M36.64%62.11M28.15%54.84M28.38%178.3M38.77%49.75M25.98%40.3M33.39%45.46M
Selling and administrative expenses 47.24%51.49M28.02%155.1M12.88%39.35M29.86%37.58M43.73%43.2M28.09%34.97M29.89%121.15M41.98%34.86M33.03%28.94M33.62%30.06M
Research and development costs -21.51%15.6M17.43%67.11M-3.89%14.31M23.36%14.01M22.80%18.91M28.25%19.87M25.28%57.15M31.78%14.89M11.00%11.36M32.96%15.4M
Operating profit 45.11%-20.26M-29.01%-124.86M30.89%-19.12M-56.09%-27.39M-60.41%-41.45M-43.41%-36.91M-47.68%-96.78M-89.32%-27.66M-29.96%-17.55M-67.98%-25.84M
Net non-operating interest income expense -20.37%-7.76M-3.15%-27.88M-5.26%-7.52M-15.97%-6.82M7.81%-7.1M-2.19%-6.45M19.61%-27.03M14.61%-7.14M30.50%-5.88M11.19%-7.7M
Non-operating interest income -57.76%931K-32.99%5.97M-67.71%908K-57.34%1.18M9.32%1.68M22.58%2.2M237.03%8.9M287.33%2.81M230.18%2.76M252.64%1.53M
Non-operating interest expense 2.88%4.19M22.55%15.35M-3.08%3.77M23.96%3.37M19.39%4.13M66.24%4.07M-14.91%12.52M8.53%3.89M-28.68%2.72M-7.98%3.46M
Total other finance cost -1.68%4.51M-20.96%18.5M-23.22%4.66M-21.88%4.62M-19.56%4.64M-19.03%4.58M8.63%23.41M10.14%6.06M7.96%5.92M8.03%5.77M
Other net income (expense) -258.89%-323K-192.58%-670K91.94%-5K-24.68%-197K-317.24%-378K50.82%-90K-127.33%-229K-107.64%-62K-322.54%-158K680.00%174K
Gain on sale of security ------------21.88%-4.62M19.56%-4.64M19.03%-4.58M-8.63%-23.41M-10.14%-6.06M-7.96%-5.92M-8.03%-5.77M
Other non- operating income (expenses) -258.89%-323K-192.58%-670K91.94%-5K-24.68%-197K-317.24%-378K50.82%-90K-127.33%-229K-107.64%-62K-322.54%-158K680.00%174K
Income before tax 34.76%-28.35M-23.68%-153.42M23.59%-26.64M-45.88%-34.4M-46.64%-48.93M-34.81%-43.45M-26.16%-124.04M-57.31%-34.86M-7.74%-23.58M-38.55%-33.37M
Income tax -1,317.35%-4.77M-97.25%78K-110.38%-275K-1,258.24%-1.05M2,571.05%1.02M625.93%392K-27.76%2.83M-31.27%2.65M1,111.11%91K-29.63%38K
Net income 46.23%-23.57M-20.98%-153.49M29.72%-26.36M-40.87%-33.35M-49.51%-49.94M-35.80%-43.84M-24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M
Net income continuous Operations 46.23%-23.57M-20.98%-153.49M29.72%-26.36M-40.87%-33.35M-49.51%-49.94M-35.80%-43.84M-24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M
Minority interest income
Net income attributable to the parent company 46.23%-23.57M-20.98%-153.49M29.72%-26.36M-40.87%-33.35M-49.51%-49.94M-35.80%-43.84M-24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 46.23%-23.57M-20.98%-153.49M29.72%-26.36M-40.87%-33.35M-49.51%-49.94M-35.80%-43.84M-24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M
Basic earnings per share 48.91%-0.47-7.77%-3.1932.50%-0.54-35.29%-0.69-28.05%-1.05-5.75%-0.9216.62%-2.96-21.21%-0.825.00%-0.5120.39%-0.82
Diluted earnings per share 48.91%-0.47-7.77%-3.1932.50%-0.54-35.29%-0.69-28.05%-1.05-5.75%-0.9216.62%-2.96-21.21%-0.825.00%-0.5120.39%-0.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.30%
Sample Name
Sample Code
 +1.74%
Sample Name
Sample Code
 -2.97%
4
ProShares Ultra Energy
DIG
-3.36%
5
VanEck Oil Services ETF
OIH
-3.68%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.26%
Sample Name
Sample Code
 +9.96%
Sample Name
Sample Code
 +7.61%
4
United Microelectronics
UMC
+6.78%
5
NetEase
NTES
+5.85%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -